ArticleJournal of autism and developmental disorders2026
Prevalence of Co-occurring Mental, Neurodevelopmental and Neurological Conditions in Medicaid Beneficiaries With Autism.
Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeAs more children with autism enter adulthood, updated data on co-occurring conditions throughout the lifespan are needed. We examined mental, neurodevelopmental and neurological (MNN) conditions among people with and without autism overall and by demographics.
methodsUsing Medicaid claims data for beneficiaries aged ≥ 1 year enrolled during 2020, we identified autism and MNN diagnoses using ICD-10 codes. Adjusted prevalence ratios (aPRs) in beneficiaries with versus without autism were calculated using log-binomial models.
resultsAmong 993,965 beneficiaries with autism, attention-deficit-hyperactivity and conduct disorders (ADHD/CD, 30.5%), intellectual disabilities (ID, 20.4%), and anxiety disorders (19.3%) were most common. Prevalence of every condition except ADHD/CD increased with age and was higher in females. For most conditions, prevalence was lowest in American Indian/Alaska Native (AI/AN) and Hispanic individuals. Every condition except alcohol/drug use disorders was significantly more prevalent in those with autism; aPRs ranged from 1.8 (depression) to 21.2 (ID). APRs were higher in middle and older ages for neurodevelopmental conditions, in children and adolescents for mental and neurological conditions, and in women for neurodevelopmental and neurological conditions. AI/AN beneficiaries had the highest aPRs for nearly all conditions.
conclusionAmong publicly-insured individuals, MNN conditions were more common in beneficiaries with than without autism across the lifespan, in both sexes and across racial/ethnic groups. Demographic variation may reflect underdiagnosis of autism in previous generations and females, respectively, and less access to mental health services in some racial/ethnic groups. Screening for ADHD and mental health disorders in youth and adults with autism may improve health outcomes. Screening for ADHD and mental health disorders in youth and adults with autism may improve health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.